UBS Group AG - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONMED CORP
ValueSharesWeighting
Q2 2022$1,000
-90.0%
1,000
-88.9%
0.00%
Q3 2020$10,000
+42.9%
9,000
+28.6%
0.00%
Q2 2020$7,0007,0000.00%
Other shareholders
CONMED CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 50,065,000$86,599,0006.97%
III Capital Management 12,488,000$21,464,0001.87%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,035,000$6,946,0001.55%
SHENKMAN CAPITAL MANAGEMENT INC 6,082,000$10,261,0001.29%
SSI INVESTMENT MANAGEMENT LLC 6,448,000$11,078,0000.60%
MACKAY SHIELDS LLC 38,008,000$65,472,0000.58%
Eisler Capital (UK) Ltd. 9,500,000$16,280,0000.27%
CAPSTONE INVESTMENT ADVISORS, LLC 53,974,000$93,024,0000.26%
OSTERWEIS CAPITAL MANAGEMENT INC 2,607,000$4,493,0000.25%
Polar Asset Management Partners Inc. 10,000,000$17,137,0000.18%
View complete list of CONMED CORP shareholders